Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited by BY PAM BELLUCK


Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.

Published: June 22, 2021 at 04:55AM

from NYT Health https://ift.tt/2TSOAUm